Patent Assignment
Reel/Frame 059435/0777
Assignment of Assignor's Interest
Recorded: 2022-03-18
Pages: 29
Assignor
ARGENX SE
Executed: 2017-05-05
Assignee
ARGENX BVBA
INDUSTRIEPARK 7, GENT, 9052, BELGIUM
Covered Properties
(2)
Antibodies to CD70
Fcrn Antagonists and Methods of Use
Application:
17/672,346 →
Publication:
US 2022/0275035
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Mar 18, 2022
From: ARGEN-X N.V.
To: ARGENX SE
Reel/Frame 059439/0109 →
Change of Name
Mar 18, 2022
From: ARGEN-X N.V.
To: ARGENX SE
Reel/Frame 059439/0578 →
Assignment of Assignor's Interest
Mar 18, 2022
From: ULRICHTS, PETER; BLANCHETOT, CHRISTOPHE; DREIER, TORSTEN; DE HAARD, JOHANNES
To: ARGEN-X N.V.
Reel/Frame 059302/0198 →
Assignment of Assignor's Interest
Mar 18, 2022
From: OBER, E. SALLY WARD
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 059302/0246 →
Assignment of Assignor's Interest
Mar 18, 2022
From: SILENCE, KAREN; ULRICHTS, PETER; DE HAARD, JOHANNES JOSEPH WILHELMUS; DREIER, TORSTEN
To: ARGEN-X B.V.
Reel/Frame 059302/0912 →
Change of Name
Apr 8, 2022
From: ARGENX BVBA
To: ARGENX BV
Reel/Frame 059539/0878 →
Change of Name
Apr 29, 2022
From: ARGEN-X B.V.
To: ARGEN-X N.V.
Reel/Frame 060361/0610 →
Change of Name
Feb 8, 2023
From: ARGENX BVBA
To: ARGENX BV
Reel/Frame 062631/0610 →